Re: CKD Reata / Market Cap
in response to
by
posted on
May 04, 2019 08:16AM
Reata phase two data on GFR increase is based on historical controls and here I was quibbling with you about the marginal p value for our data against placebo :)
The more I research RVX it is hard not to get excited about the upcoming results. If successfull, as I now believe they will be, this will be the start of a new paradigm in medicine.